NASDAQ
Aldeyra Therapeutics, Inc. (ALDX) has a current ratio of 2.58x as of Monday, May 25, 2026. This represents a 76.42% decrease compared to its 12-month average of 10.95x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.